lung cancer tissues; adjacent normal tissues; tumor tissues; non-tumor tissues; tumor tissues from xenograft models
A549; H1299; HBE
cell line-derived xenograft
ceRNA regulation (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); cell cycle (promotes); stemness (promotes); other pathway/process (promotes)
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Transfection; Colony Formation Assay; EdU Staining; Transwell Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Western Blot; Luciferase Reporter Assay; RNA Pull-Down; In Vivo Animal Model; IHC (Immunohistochemistry)
Circ_0060937 was highly expressed in lung cancer clinical tissues and may be a therapeutic target for lung cancer.
Circ_0060937 is up-regulated in lung cancer tissues and A549/H1299 lung cancer cells. It acts as an oncogenic circRNA that promotes proliferation, migration, invasion, sphere formation, cell cycle progression, and xenograft tumor growth while suppressing apoptosis. Mechanistically, circ_0060937 binds miR-1304-5p and relieves miR-1304-5p-mediated repression of LAD1, thereby activating the circ_0060937/miR-1304-5p/LAD1 regulatory axis.
0.7554
Circ_0060937 Contributes to the Development of Lung Cancer via Positively Regulating LAD1 Expression by Binding to miR-1304-5p.
combined biological and clinical study